Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
02/2005
02/24/2005US20050043566 Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
02/24/2005US20050043556 2,2'-Bis(triphenylphosphino)biphenyls complexed with a transition metal-diamine complex; highly active and selective hydrogenation catalysts for the hydrogenation of ketones and imines to alcohols and amines, respectively, used as drug intermediates often required in single isomer form; very low loading
02/24/2005US20050043553 Synthesis of triphenylphosphonium quinols and quinones
02/24/2005US20050043541 five-coordinate metal complex, a salt, a solvate or an enantiomer comprising a carbene ligand, a multidentate ligand and a constraint steric hindrance ligand having a pKa of >15; high activity at moderate temperatures; narrow molecular weight distribution addition polymers; unsaturation reactions
02/24/2005US20050043540 such as cis-4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]-N-methyl-N-(3-phenyl-2(E)-propenyl)-benzenemethanamine;
02/24/2005US20050043534 Modulators of ceramidase and methods of used based thereon
02/24/2005US20050043507 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
02/24/2005US20050043496 Catalysts for olefin polymerization
02/24/2005US20050043449 Ultraviolet radiation transparency and reflectance; satellites
02/24/2005US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants
02/24/2005US20050043340 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
02/24/2005US20050043279 Novel phosphinine compounds and metal complexes thereof
02/24/2005US20050043278 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X
02/24/2005US20050043277 Production of imidazole derivatives and novel intermediates of the derivatives
02/24/2005US20050043276 phenyl or thien-2-yl substituted amide methyl phosphonate or phosphonyl halide derivatives; do not require a beta -lactam pharmacophore; bactericides; antibiotic resistance
02/24/2005US20050043244 Sulfur compounds such as 4-(N-(1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)hydrazin-2-yl-carbonayl)-N -methyaminomethyl)phenyl oxycarbonyl-glutamic acid, used as sulfonyl hydrazine prodrugs(SHPs) having antitumor activity in mammals
02/24/2005US20050042888 Precursor compositions and processes for MOCVD of barrier materials in semiconductor manufacturing
02/24/2005US20050042195 New polymer and polymer light-emitting device using the same
02/24/2005DE10335950A1 Hydroxy-substituted 5,5'-bis-allylalkylbisphenyls with phosphine groups in positions 2 and 2' useful as ligands in hydrogenation/isomerization catalysts are new
02/24/2005DE10331500A1 Neue Acridin-Derivate und deren Verwendung als Arzneimittel New acridine derivatives and their use as medicaments
02/24/2005CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent
02/24/2005CA2534819A1 Transition metal carbide and nitride containing catalysts, their preparation and use as oxidation and dehydrogenation catalysts
02/24/2005CA2533488A1 Aqueous lecithin dispersions
02/23/2005EP1508345A1 Absorbents and devices for the reduction of small organic compounds from blood products
02/23/2005EP1507784A1 Amorphous solid modification of bis(2,4-dicumylphenyl) pentaerythritol diphosphite
02/23/2005EP1507783A1 Hydroxy diphosphines and their use in catalysis
02/23/2005EP1214282B1 Hydroformylation process utilizing multidentate phosphite ligands
02/23/2005EP1053220B1 Improved separation processes
02/23/2005CN1583769A 9-[2-(phosphonomethoxy)ethyl] adenine bicycloalkoxide and its preparation
02/23/2005CN1583768A Preparation of N, N-di(2-ethoxyl) aminomethyl diethyl phosphoric acid
02/23/2005CN1583767A Synthesis of fatty amine phosphoric triamine
02/23/2005CN1583766A Extraction of phosphatidyl serine from brains of animals
02/23/2005CN1583765A Method for preparing powdery phosphatide by alkali emulsion phosphatide
02/23/2005CN1190442C Bis-phosphinimine catalyst
02/23/2005CN1190441C Phosphine sulfide preparing process and use thereof
02/22/2005US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors
02/22/2005US6858733 Compounds for generating chemiluminescence with a peroxidase
02/22/2005US6858727 Intermediate of carbapenem antibiotics and process for the preparation thereof
02/22/2005US6858691 Exhibit extensive delocalization of the negative charge and good activity in polymerization or in copolymerization and allow the preparation of macromolecules possessing dissociated and stable ionic functional groups
02/22/2005US6858688 Amino acid complexes and the use thereof in producing olefin polymers
02/22/2005US6858662 For stabilizing rubbers, plastic resins, lubricating oils, petroleum fuels, waxes, and organic liquids
02/22/2005US6858584 For therapy of bacterial disease in a mammal; side effect reduction
02/22/2005US6858557 Supported constrained geometry olefin polymerization catalysts
02/22/2005US6858393 Chain terminators for DNA synthesis
02/22/2005US6858226 Fusogenic lipids and vesicles
02/17/2005WO2005014669A1 Improved method of preparing a hydrocarbylated metal-organic compound
02/17/2005WO2005014666A1 Process for the preparation of a metal-organic compound comprising at least one imine ligand
02/17/2005WO2005014665A1 Process for the preparation of a metalloorganic compound comprising at least one imine ligand
02/17/2005WO2005014664A1 Process for the preparation of a metal-organic compound comprising at least one imine ligand
02/17/2005WO2005014663A1 Process for the preparation of an metalloorganic compound comprising at least one imine ligand
02/17/2005WO2005014606A1 A process for the preparation of acylphosphines
02/17/2005WO2005014605A1 Process for preparing acylphosphanes and derivatives thereof
02/17/2005WO2005014603A1 Phosphinane compounds with immunomodulating activity
02/17/2005WO2005014581A2 Lanthanide complexes preparation and uses thereof
02/17/2005WO2005014541A1 Novel antihypercholesterolemic compound
02/17/2005WO2005014536A2 Podophyllotoxin derivatives
02/17/2005WO2005014535A1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same
02/17/2005WO2005014525A2 Bi-aryl compound having immunosuppressive activity
02/17/2005WO2004094439A3 Method for the production of acylphosphines
02/17/2005WO2004075860A3 Process for purification of zoledronic acid
02/17/2005WO2004067489A8 Hydroxyl compounds and compositions for cholesterol management and related uses
02/17/2005WO2003099192A8 Bis-aromatic alkanols
02/17/2005US20050038279 Proces for the preparation of 9, 10-dihydro-9-oxa-10-organylphosphaphenanthrene-10-oxide and derivatives of the same substituted on the phenyl groups
02/17/2005US20050038278 Forming fire retardants; catalytic halogen free alkylation; simple, low cost
02/17/2005US20050038275 Quaternary onium aromatic sulfonate ether compounds or functionalized polydimethylsiloxanes
02/17/2005US20050038274 Antistatic and antidust agents, compositions thereof, and methods of manufacture
02/17/2005US20050038272 Process for preparing diphosphines
02/17/2005US20050038258 Zinc complexes capable of capturing substances having anionic substituents
02/17/2005US20050038257 Process for preparation of benzylpiperidine compounds
02/17/2005US20050038212 emulsion; ethylene or other 1-olefins; catalyst complex of nickel or palladium and a salicylaldehyde derivative with an aminopyrrolidine; high activity; highly crystalline polyethylene; narrow molecular weight distribution
02/17/2005US20050038117 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity
02/17/2005US20050038058 Novel compounds and methods for therapy
02/17/2005US20050037995 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
02/17/2005US20050037924 Reacting glyphosste and sodium hydroxide in aqueous solution; exothermic reactions
02/17/2005US20050037918 Non-metallocenes, method for the production thereof and use thereof in the polymerization of olefins
02/17/2005US20050035177 Method for preparing colloidal solution of bismuth sodium tartrate
02/17/2005US20050035060 Process for purifying glyphosate solutions by nanofiltration
02/17/2005DE10333519A1 Zweistufiges Hydroformylierungsverfahren Two-stage hydroformylation
02/17/2005DE10332291A1 Derivate von 9,10-Dihydro-9-oxa-10-phosphaphenanthren-10-oxid Derivatives of 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide
02/17/2005DE10331289A1 Neue siliciumorganische Verbindungen und ein Verfahren zu deren Herstellung New organosilicon compounds and a process for their preparation
02/17/2005DE10331288A1 Verfahren zur Herstellung von mit Phosphonsäureester modifizierten Siliconen A process for the preparation of modified with phosphonic silicones
02/17/2005CA2533698A1 Lanthanide complexes preparation and uses thereof
02/17/2005CA2533432A1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same
02/17/2005CA2533173A1 Method for the production of cyclic phosphonic acid anhydrides
02/17/2005CA2531318A1 Process for preparing acylphosphanes and derivatives thereof
02/17/2005CA2530037A1 Podophyllotoxin derivatives
02/16/2005EP1506974A1 Process for the preparation of a metalloorganic compound comprising at least one imine ligand
02/16/2005EP1506968A1 Process for the preparation of 9,10-dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxide or thiono and derivatives of the same substituted on the phenyl groups
02/16/2005EP1506959A2 Derivatised molecules for mass spectrometry
02/16/2005EP1506309A2 Plating media
02/16/2005EP1506210A2 Ascorbyl derivatives of carnitines for cosmetic compositions containing same
02/16/2005EP1506209A1 Continuous process for preparing n-phosphonomethyl glycine
02/16/2005EP1506208A2 1,1- and 1,2-bisphosphonates as apolipoprotein e modulators
02/16/2005EP1506175A1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors
02/16/2005EP1385853A4 Beta-lactamase substrates having phenolic ethers
02/16/2005EP1311519A4 Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same
02/16/2005EP0833643B1 Anhydrous alendronate monosodium salt formulations and their use for the treatment of bone diseases
02/16/2005CN1582294A Novel strong acids, process for the preparation thereof, and uses thereof
02/16/2005CN1582293A Process for preparing haptens for immunoassay of phosphorothioate pesticides
02/16/2005CN1580060A Crystal structure for medicinal compound adefovir divoxil, and its preparing method and medicine